# clm_EA063E4EB60A

subject: Amgen (/record/amgen.md)  
predicate: quarterly_operating_income  
value: 2,021,000,000 United States dollar  
valid_from: 2023-09-30  
valid_to: 2024-03-31  
published: 2023-10-31  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_603D27640F44  
last_updated: 2026-11-08  
cite: AsOf. "Amgen quarterly operating income: 2,021,000,000 United States dollar", as of 2023-09-30 (until 2024-03-31). Claim clm_EA063E4EB60A, https://asof.is/claim/clm_EA063E4EB60A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-10-31  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815423000064/0000318154-23-000064-index.htm (primary, SEC EDGAR 10-Q Q3 FY2023, published 2023-10-31)

## Supersedes

- [Amgen](/record/amgen.md) | quarterly_operating_income | 2,684,000,000 United States dollar | valid 2023-06-30 to 2023-09-30 | conf 0.95 | superseded | superseded_by [clm_EA063E4EB60A](/claim/clm_EA063E4EB60A.md) | [clm_5A3FD4672B1E](/claim/clm_5A3FD4672B1E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.